Dr. Kumar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
921 Greeley St S
Oak Park Heights, MN 55082Phone+1 651-439-1234Fax+1 651-351-0827- Is this information wrong?
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 2003 - 2006
SUNY Upstate Medical UniversityResidency, Internal Medicine, 1996 - 1999
Gandhi Medical CollegeClass of 1994
Certifications & Licensure
WI State Medical License 2021 - 2025
MN State Medical License 2003 - 2024
WV State Medical License 1999 - 2004
GA State Medical License 2002 - 2003- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer Start of enrollment: 2007 Mar 01
- Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors Start of enrollment: 2008 May 01
- Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
Publications & Presentations
PubMed
- 342 citationsPhase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck CancerEzra E.W. Cohen, Theodore Karrison, Masha Kocherginsky, Jeffrey Mueller, Robyn Egan, Chao H. Huang, Bruce Brockstein, Mark Agulnik, Bharat B. Mittal, Furhan Yunus, San...> ;Journal of Clinical Oncology. 2014 Sep 1
- 46 citationsSafety and effectiveness of bevacizumab-containing treatment for non-small-cell lung cancer: final results of the ARIES observational cohort study.Thomas J. Lynch, David R. Spigel, Julie R. Brahmer, Neal Fischbach, Jennifer Garst, Mohammad Jahanzeb, Priya Kumar, Regina M. Vidaver, Antoinette J. Wozniak, S. Fish, ...> ;Journal of Thoracic Oncology. 2014 Sep 1
- 3 citationsPhase II study of biweekly carboplatin, gemcitabine, and bevacizumab as first-line treatment in patients with stage IIIB/IV NSCLC.Arkadiusz Z. Dudek, Priya Kumar, Sunn Sunn H. Thaw, Qing Cao, Pamala A. Pawloski, Timothy Larson> ;American Journal of Clinical Oncology. 2014 Apr 1
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
M Health Fairview University of Minnesota Medical CenterMinneapolis, Minnesota
M Health Fairview Southdale HospitalMinneapolis, Minnesota- Lakeview HospitalStillwater, Minnesota
Regions HospitalSaint Paul, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
